|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 109.98 USD | -1.12% |
|
+3.57% | +9.07% |
| Capitalization | 1.34TCr 1.16TCr 1.08TCr 1TCr 1.87TCr 1,21700Cr 2.01TCr 12TCr 4.88TCr 58TCr 5.03TCr 4.93TCr 2,12000Cr | P/E ratio 2026 * |
19.4x | P/E ratio 2027 * | 17.2x |
|---|---|---|---|---|---|
| Enterprise value | 1.64TCr 1.42TCr 1.32TCr 1.23TCr 2.29TCr 1,49200Cr 2.46TCr 15TCr 5.99TCr 71TCr 6.17TCr 6.04TCr 2,59900Cr | EV / Sales 2026 * |
2.54x | EV / Sales 2027 * | 2.42x |
| Free-Float |
94.01% | Yield 2026 * |
4.49% | Yield 2027 * | 4.73% |
Last Transcript: The Clorox Company
| 1 day | -1.12% | ||
| 1 week | +3.57% | ||
| Current month | +9.07% | ||
| 1 month | +10.18% | ||
| 3 months | -6.48% | ||
| 6 months | -13.33% | ||
| Current year | +9.07% |
| 1 week | 106.33 |  | 112.2 |
| 1 month | 96.66 | | 112.2 |
| Current year | 98.75 | | 112.2 |
| 1 year | 96.66 | | 164.22 |
| 3 years | 96.66 | | 178.2 |
| 5 years | 96.66 | | 231.11 |
| 10 years | 96.66 | | 239.87 |
| Manager | Title | Age | Since |
|---|---|---|---|
Linda Rendle
CEO | Chief Executive Officer | 48 | 14/09/2020 |
Luc Bellet
DFI | Director of Finance/CFO | 48 | 01/04/2025 |
Chau Banks
CTO | Chief Tech/Sci/R&D Officer | 57 | 01/06/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Esther Lee
BRD | Director/Board Member | 67 | 19/08/2013 |
| Director/Board Member | 68 | 01/07/2015 | |
Allan Mackay
BRD | Director/Board Member | 71 | 15/08/2016 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.12% | +3.57% | -31.46% | -24.73% | 1.34TCr | |
| -0.49% | -0.97% | +25.10% | +2.07% | 5.5TCr | |
| +0.20% | +5.63% | -14.74% | +10.62% | 2.18TCr | |
| -5.04% | -6.49% | +37.25% | -48.64% | 551.24Cr | |
| -1.56% | +0.89% | -10.84% | -21.28% | 503.32Cr | |
| -0.03% | -0.06% | +2.76% | +17.70% | 292.79Cr | |
| +0.10% | +7.89% | -11.36% | +17.38% | 276.46Cr | |
| -1.41% | -2.22% | +17.60% | +74.22% | 149.74Cr | |
| -0.76% | -2.34% | -35.06% | +29.30% | 103.06Cr | |
| -2.41% | +7.52% | +27.05% | +225.50% | 91Cr | |
| Average | -1.25% | +1.30% | +0.63% | +28.21% | 1.1TCr | |
| Weighted average by Cap. | -0.71% | +0.98% | +7.10% | +0.77% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 648.72Cr 559.26Cr 520.63Cr 484.69Cr 902.44Cr 59TCr 970.94Cr 5.99TCr 2.36TCr 28TCr 2.43TCr 2.38TCr 1,02500Cr | 679.16Cr 585.51Cr 545.06Cr 507.43Cr 944.78Cr 62TCr 1.02TCr 6.27TCr 2.47TCr 29TCr 2.55TCr 2.49TCr 1,07300Cr |
| Net income | 70Cr 61Cr 56Cr 52Cr 98Cr 6.37TCr 105.11Cr 648.32Cr 255.64Cr 3.04TCr 263.36Cr 257.94Cr 11TCr | 79Cr 68Cr 64Cr 59Cr 110.48Cr 7.21TCr 118.87Cr 733.2Cr 289.11Cr 3.44TCr 297.84Cr 291.71Cr 13TCr |
| Net Debt | 303.18Cr 261.37Cr 243.32Cr 226.52Cr 421.75Cr 28TCr 453.77Cr 2.8TCr 1.1TCr 13TCr 1.14TCr 1.11TCr 48TCr | 304.82Cr 262.78Cr 244.63Cr 227.74Cr 424.03Cr 28TCr 456.22Cr 2.81TCr 1.11TCr 13TCr 1.14TCr 1.12TCr 48TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/26/16 | 109.98 $ | -1.12% | 19,19,965 |
| 15/26/15 | 111.23 $ | -0.16% | 19,71,431 |
| 14/26/14 | 111.41 $ | +2.34% | 21,52,488 |
| 13/26/13 | 108.86 $ | +1.76% | 17,85,683 |
| 12/26/12 | 106.98 $ | +0.74% | 22,43,458 |
Delayed Quote Nyse, January 17, 2026 at 02:30 am IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CLX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition